ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1]
Publication
, Journal Article
Sherman, CR; Fernandez, H; MacIntyre, N; Brougher, P
Published in: Respiratory Care
December 1, 1991
Duke Scholars
Published In
Respiratory Care
ISSN
0098-9142
Publication Date
December 1, 1991
Volume
36
Issue
12
Start / End Page
1439 / 1441
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sherman, C. R., Fernandez, H., MacIntyre, N., & Brougher, P. (1991). ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1]. Respiratory Care, 36(12), 1439–1441.
Sherman, C. R., H. Fernandez, N. MacIntyre, and P. Brougher. “ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1].” Respiratory Care 36, no. 12 (December 1, 1991): 1439–41.
Sherman CR, Fernandez H, MacIntyre N, Brougher P. ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1]. Respiratory Care. 1991 Dec 1;36(12):1439–41.
Sherman, C. R., et al. “ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1].” Respiratory Care, vol. 36, no. 12, Dec. 1991, pp. 1439–41.
Sherman CR, Fernandez H, MacIntyre N, Brougher P. ICN spokesmen emphasize virazole (ribavirin) efficacy and safety [1]. Respiratory Care. 1991 Dec 1;36(12):1439–1441.
Published In
Respiratory Care
ISSN
0098-9142
Publication Date
December 1, 1991
Volume
36
Issue
12
Start / End Page
1439 / 1441
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology